These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19299636)

  • 1. Results of the MRI substudy of the intravenous magnesium efficacy in stroke trial.
    Kidwell CS; Lees KR; Muir KW; Chen C; Davis SM; De Silva DA; Weir CJ; Starkman S; Alger JR; Saver JL;
    Stroke; 2009 May; 40(5):1704-9. PubMed ID: 19299636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical diffusion mismatch better discriminates infarct growth than mean transit time-diffusion weighted imaging mismatch in patients with middle cerebral artery-M1 occlusion and limited infarct core.
    Nogueira RG; Kemmling A; Souza LM; Payabvash S; Hirsch JA; Yoo AJ; Lev MH
    J Neurointerv Surg; 2017 Feb; 9(2):127-130. PubMed ID: 26957483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the Glycine Antagonist Gavestinel on cerebral infarcts in acute stroke patients, a randomized placebo-controlled trial: The GAIN MRI Substudy.
    Warach S; Kaufman D; Chiu D; Devlin T; Luby M; Rashid A; Clayton L; Kaste M; Lees KR; Sacco R; Fisher M;
    Cerebrovasc Dis; 2006; 21(1-2):106-11. PubMed ID: 16340185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensive versus subcutaneous insulin in patients with hyperacute stroke: results from the randomized INSULINFARCT trial.
    Rosso C; Corvol JC; Pires C; Crozier S; Attal Y; Jacqueminet S; Deltour S; Multlu G; Leger A; Meresse I; Payan C; Dormont D; Samson Y
    Stroke; 2012 Sep; 43(9):2343-9. PubMed ID: 22700528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial.
    Muir KW; Lees KR; Ford I; Davis S;
    Lancet; 2004 Feb; 363(9407):439-45. PubMed ID: 14962524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose optimization of intravenous magnesium sulfate after acute stroke.
    Muir KW; Lees KR
    Stroke; 1998 May; 29(5):918-23. PubMed ID: 9596235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of perfusion computed tomography with diffusion-weighted magnetic resonance imaging in hyperacute ischemic stroke.
    Bisdas S; Donnerstag F; Ahl B; Bohrer I; Weissenborn K; Becker H
    J Comput Assist Tomogr; 2004; 28(6):747-55. PubMed ID: 15538146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remote ischemic perconditioning in thrombolysed stroke patients: randomized study of activating endogenous neuroprotection - design and MRI measurements.
    Hougaard KD; Hjort N; Zeidler D; Sørensen L; Nørgaard A; Thomsen RB; Jonsdottir K; Mouridsen K; Hansen TM; Cho TH; Nielsen TT; Bøtker HE; Østergaard L; Andersen G
    Int J Stroke; 2013 Feb; 8(2):141-6. PubMed ID: 22463392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prehospital use of magnesium sulfate as neuroprotection in acute stroke.
    Saver JL; Starkman S; Eckstein M; Stratton SJ; Pratt FD; Hamilton S; Conwit R; Liebeskind DS; Sung G; Kramer I; Moreau G; Goldweber R; Sanossian N;
    N Engl J Med; 2015 Feb; 372(6):528-36. PubMed ID: 25651247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter, randomized, double-blind, placebo-controlled trial to test efficacy and safety of magnetic resonance imaging-based thrombolysis in wake-up stroke (WAKE-UP).
    Thomalla G; Fiebach JB; Østergaard L; Pedraza S; Thijs V; Nighoghossian N; Roy P; Muir KW; Ebinger M; Cheng B; Galinovic I; Cho TH; Puig J; Boutitie F; Simonsen CZ; Endres M; Fiehler J; Gerloff C;
    Int J Stroke; 2014 Aug; 9(6):829-36. PubMed ID: 23490032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of collateral blood flow is associated with infarct growth in ischemic stroke.
    Campbell BC; Christensen S; Tress BM; Churilov L; Desmond PM; Parsons MW; Barber PA; Levi CR; Bladin C; Donnan GA; Davis SM;
    J Cereb Blood Flow Metab; 2013 Aug; 33(8):1168-72. PubMed ID: 23652626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
    Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
    Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visual assessment of magnetic resonance imaging perfusion lesions in a large patient group.
    Siemonsen S; Fitting T; Thomalla G; Krützelmann A; Fiehler J
    Clin Neuroradiol; 2012 Dec; 22(4):305-13. PubMed ID: 22484907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing response to stroke thrombolysis: validation of 24-hour multimodal magnetic resonance imaging.
    Campbell BC; Tu HT; Christensen S; Desmond PM; Levi CR; Bladin CF; Hjort N; Ashkanian M; Sølling C; Donnan GA; Davis SM; Ostergaard L; Parsons MW
    Arch Neurol; 2012 Jan; 69(1):46-50. PubMed ID: 21911654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perfusion MR predicts outcome in high-risk transient ischemic attack/minor stroke: a derivation-validation study.
    Asdaghi N; Hill MD; Coulter JI; Butcher KS; Modi J; Qazi A; Goyal M; Demchuk AM; Coutts SB
    Stroke; 2013 Sep; 44(9):2486-92. PubMed ID: 23908062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of baseline magnetic resonance imaging (MRI) apparent diffusion coefficient lesion volume on functional outcome in ischemic stroke.
    Ma L; Gao PY; Hu QM; Lin Y; Jing LN; Xue J; Chen ZJ; Wang YJ; Liu ML; Cai YF
    Neurol Res; 2011 Jun; 33(5):494-502. PubMed ID: 21669118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Citicoline 010 Investigators.
    Warach S; Pettigrew LC; Dashe JF; Pullicino P; Lefkowitz DM; Sabounjian L; Harnett K; Schwiderski U; Gammans R
    Ann Neurol; 2000 Nov; 48(5):713-22. PubMed ID: 11079534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A topographic study of the evolution of the MR DWI/PWI mismatch pattern and its clinical impact: a study by the EPITHET and DEFUSE Investigators.
    Ogata T; Nagakane Y; Christensen S; Ma H; Campbell BC; Churilov L; Olivot JM; Desmond PM; Albers GW; Davis SM; Donnan GA;
    Stroke; 2011 Jun; 42(6):1596-601. PubMed ID: 21512174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stroke With Unknown Time of Symptom Onset: Baseline Clinical and Magnetic Resonance Imaging Data of the First Thousand Patients in WAKE-UP (Efficacy and Safety of MRI-Based Thrombolysis in Wake-Up Stroke: A Randomized, Doubleblind, Placebo-Controlled Trial).
    Thomalla G; Boutitie F; Fiebach JB; Simonsen CZ; Nighoghossian N; Pedraza S; Lemmens R; Roy P; Muir KW; Ebinger M; Ford I; Cheng B; Galinovic I; Cho TH; Puig J; Thijs V; Endres M; Fiehler J; Gerloff C;
    Stroke; 2017 Mar; 48(3):770-773. PubMed ID: 28174327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.